These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10546893)

  • 21. Characterization of a second member of the sentrin family of ubiquitin-like proteins.
    Kamitani T; Kito K; Nguyen HP; Fukuda-Kamitani T; Yeh ET
    J Biol Chem; 1998 May; 273(18):11349-53. PubMed ID: 9556629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DeSUMOylating enzymes--SENPs.
    Drag M; Salvesen GS
    IUBMB Life; 2008 Nov; 60(11):734-42. PubMed ID: 18666185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
    Kim YH; Choi CY; Kim Y
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12350-5. PubMed ID: 10535925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers.
    Rosas-Acosta G; Russell WK; Deyrieux A; Russell DH; Wilson VG
    Mol Cell Proteomics; 2005 Jan; 4(1):56-72. PubMed ID: 15576338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUMO-1 modification activates the transcriptional response of p53.
    Rodriguez MS; Desterro JM; Lain S; Midgley CA; Lane DP; Hay RT
    EMBO J; 1999 Nov; 18(22):6455-61. PubMed ID: 10562557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding interface between an E2 (UBC9) and a ubiquitin homologue (UBL1).
    Liu Q; Jin C; Liao X; Shen Z; Chen DJ; Chen Y
    J Biol Chem; 1999 Jun; 274(24):16979-87. PubMed ID: 10358047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of SENP7, a SUMO-2/3-specific isopeptidase.
    Shen LN; Geoffroy MC; Jaffray EG; Hay RT
    Biochem J; 2009 Jun; 421(2):223-30. PubMed ID: 19392659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate link between NF-kappaB activity and ubiquitin-like modifiers.
    Lang V; Rodríguez MS
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):853-7. PubMed ID: 18793150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination.
    Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Furuichi K; Tanaka K
    Biochem Biophys Res Commun; 1999 Mar; 256(1):121-6. PubMed ID: 10066434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of sentrinized proteins by a novel sentrin-specific protease.
    Gong L; Millas S; Maul GG; Yeh ET
    J Biol Chem; 2000 Feb; 275(5):3355-9. PubMed ID: 10652325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The ubiquitin world: a novel cellular control system].
    Yokosawa H
    Tanpakushitsu Kakusan Koso; 1999 May; 44(6):732-6. PubMed ID: 10341544
    [No Abstract]   [Full Text] [Related]  

  • 32. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.
    Rodríguez JA
    Semin Cancer Biol; 2014 Aug; 27():11-9. PubMed ID: 24704338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SUMO--nonclassical ubiquitin.
    Melchior F
    Annu Rev Cell Dev Biol; 2000; 16():591-626. PubMed ID: 11031248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ubiquitin-like proteins and its ligation systems].
    Chiba T; Osaka F
    Tanpakushitsu Kakusan Koso; 1999 May; 44(6):744-51. PubMed ID: 10341546
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex.
    Gong L; Li B; Millas S; Yeh ET
    FEBS Lett; 1999 Apr; 448(1):185-9. PubMed ID: 10217437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beginning at the end with SUMO.
    Matunis MJ; Pickart CM
    Nat Struct Mol Biol; 2005 Jul; 12(7):565-6. PubMed ID: 15999109
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1.
    Macauley MS; Errington WJ; Okon M; Schärpf M; Mackereth CD; Schulman BA; McIntosh LP
    J Biol Chem; 2004 Nov; 279(47):49131-7. PubMed ID: 15355965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.
    Matunis MJ; Coutavas E; Blobel G
    J Cell Biol; 1996 Dec; 135(6 Pt 1):1457-70. PubMed ID: 8978815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification in reverse: the SUMO proteases.
    Mukhopadhyay D; Dasso M
    Trends Biochem Sci; 2007 Jun; 32(6):286-95. PubMed ID: 17499995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin-like proteins: new wines in new bottles.
    Yeh ET; Gong L; Kamitani T
    Gene; 2000 May; 248(1-2):1-14. PubMed ID: 10806345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.